The Mainstream Patient: July 6
This week we feature articles about the rise in plastic surgery procedures and ‘tweakments’ during the COVID-19 pandemic, uses for aloe vera in skincare, retinol use for acne, plus more.
Related Articles
Addressing Disparities in Skin-Aging Prevention Among Women of Color
A recent survey covered topics including skin-aging prevention, care-seeking behavior, trust in professionals, and more.
Biologic Therapy Linked to Increased Density of Demodex Mites and Prevalence of Demodicosis in Patients With Psoriasis vs Controls
A cross-sectional study revealed an increase and heightened prevalence of Demodex and demodicosis in individuals with psoriasis receiving biologic therapy.
Patients With Hidradenitis Suppurativa Have Increased Odds of Respiratory Disease, According to Study Findings
Researchers conducted a population-based study examining a sample of patients with HS during hospital admissions.
Expert Insights: Unmet Needs in Topical Treatment for Atopic Dermatitis
Linda Stein-Gold, MD, and Michael Cameron, MD, FAAD, discuss the need for non-steroidal treatment options in atopic dermatitis management, driven by patient preferences. They highlight…
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers
In online discussion April 23,commissioners cited health care specifically among their reasons for supporting the ban.
Facial Skin Cancer Surgery Yields Low and Improved Scores For Perceived Stigmatization, Body Image Concerns, and Psychosocial Distress
A review found that Mohs micrographic surgery and conventional excision yielded comparable patient reported outcomes.
US Central and European Commands Should Revisit Disallowance of Systemic Treatments for Deployed Individuals With Psoriasis, Eczema, Paper Argues
At present, deployed members of the military are not permitted to be receiving therapy with systemic therapies such as immunomodulators and biologics.
Upadacitinib Outperforms Dupilumab in Primary and Secondary End Points in Head-to-Head AD Study
In LEVEL-UP, upadacitinib demonstrated superiority over dupilumab in achieving EASI-90 and little to no itch at week 16.
Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis
Posters from the Academy of Managed Care Pharmacy annual meeting featured studies on atopic dermatitis.